Coming very soon, page-95

I think this may have been AbbVie. If it is AbbVie they let the exclusivity period for Lisa expire after delivery of the final customized AI in November.

From Page 90 of the 10K

"During the fiscal year ended June 30, 2016, the Company recognized $5.3 million in revenue related to services rendered on a time and materials basis, proportional performance method, the completed contract method and/or straight line basis over the requisite service period pursuant to customer agreements to provide various customization and development services. During the fiscal year ended June 30, 2016, the Company recognized $5.0 million in revenue related to an agreement with a customer to provide exclusivity for a defined period of time to evaluate certain drug delivery alternatives as the requisite exclusivity period expired during the fiscal year."